InvestSMART

Clinuvel Pharmaceuticals Limited (ASX: CUV) - Announcements

- Current share price for CUV : $7.570

ASX company news and announcements for Clinuvel Pharmaceuticals Limited (CUV) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Clinuvel Pharmaceuticals Limited (CUV) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Clinuvel Pharmaceuticals Limited (CUV), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Clinuvel Pharmaceuticals Limited (CUV)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$382 Results of Meeting 6 Nov 2026 12:17PM $7.470 $7.570 risen by 1.34%
$382 Chair address - amendment 6 Nov 2026 12:15PM $7.470 $7.570 risen by 1.34%
$382 Managing Director Address 6 Nov 2026 9:59AM $7.740 $7.570 fallen by 2.20%
$382 Chair address 6 Nov 2026 9:55AM $7.740 $7.570 fallen by 2.20%
$382 CLINUVEL files NEURACTHEL Instant dossier 30 Oct 2026 8:30AM $7.330 $7.570 risen by 3.27%
$382 Notification of cessation of securities - CUV 15 Oct 2026 8:18AM $7.610 $7.570 fallen by 0.53%
$382 Section 708A Cleansing Statement 6 Oct 2026 8:54AM $8.160 $7.570 fallen by 7.23%
$382 Notification of cessation of securities - CUV 6 Oct 2026 8:53AM $8.160 $7.570 fallen by 7.23%
$382 Application for quotation of securities - CUV 6 Oct 2026 8:51AM $8.160 $7.570 fallen by 7.23%
$382 Change in substantial holding 6 Oct 2026 8:17AM $8.160 $7.570 fallen by 7.23%
$382 Change in substantial holding 2 Oct 2026 6:56PM $8.100 $7.570 fallen by 6.54%
$382 Notice of Annual General Meeting/Proxy Form 2 Oct 2026 8:57AM $8.250 $7.570 fallen by 8.24%
$382 New CUV105 vitiligo cases presented to EADV 1 Oct 2026 11:18AM $8.450 $7.570 fallen by 10.41%
$382 Becoming a substantial holder 24 Sep 2026 8:19AM $8.280 $7.570 fallen by 8.57%
$382 CLINUVEL date of Annual General Meeting 18 Sep 2026 5:12PM $8.370 $7.570 fallen by 9.56%
$382 CLINUVEL develops proprietary ZEROKIN device 8 Sep 2026 9:32AM $8.160 $7.570 fallen by 7.23%
$382 Ceasing to be a substantial holder 2 Sep 2026 8:15AM $8.240 $7.570 fallen by 8.13%
$382 CLINUVEL considers Nasdaq listing, ASX delisting 27 Aug 2026 12:33PM $10.690 $7.570 fallen by 29.19%
$382 Investor Presentation 27 Aug 2026 12:28PM $10.690 $7.570 fallen by 29.19%
$382 Appendix 4G 27 Aug 2026 12:26PM $10.690 $7.570 fallen by 29.19%
$382 Corporate Governance Statement 27 Aug 2026 12:25PM $10.690 $7.570 fallen by 29.19%
$382 Dividend/Distribution - CUV 27 Aug 2026 12:24PM $10.690 $7.570 fallen by 29.19%
$382 A decade of profitability provides U.S. expansion foundation 27 Aug 2026 12:22PM $10.690 $7.570 fallen by 29.19%
$382 Appendix 4E and Annual Report to Shareholders 2026 27 Aug 2026 12:21PM $10.690 $7.570 fallen by 29.19%
$382 CLINUVEL Annual Results - Investor Webinar 20 Aug 2026 9:07AM $10.400 $7.570 fallen by 27.21%

1 - 25 of 886 results

Page 1 of 36

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.